These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8741942)

  • 1. Effect of NMDA receptor antagonists on D1, D2 and D1/D2 mediated behaviors in intact rats.
    Dall'Olio R; Rimondini R; Gandolfi O
    Psychopharmacology (Berl); 1996 Jan; 123(2):187-90. PubMed ID: 8741942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.
    Starr MS; Starr BS
    Psychopharmacology (Berl); 1994 Apr; 114(3):469-76. PubMed ID: 7855205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.
    Dall'Olio R; Rimondini R; Gandolfi O
    Psychopharmacology (Berl); 1995 Apr; 118(3):310-5. PubMed ID: 7617824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic neonatal blockade of N-methyl-D-aspartate receptor by CGP 39551 increases dopaminergic function in adult rat.
    Dall'Olio R; Facchinetti F; Contestabile A; Gandolfi O
    Neuroscience; 1994 Nov; 63(2):451-5. PubMed ID: 7891857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the serotonergic system counteracts the dizocilpine-induced changes in dopaminergic function.
    Dall'Olio R; Gandolfi O; Gaggi R
    Behav Pharmacol; 2000 Feb; 11(1):29-36. PubMed ID: 10821206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K; Czyrak A; Maćkowiak M; Fijał K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
    Kinoshita H; Hasegawa T; Kameyama T; Yamamoto I; Nabeshima T
    Neurosci Lett; 1994 Jun; 174(1):101-4. PubMed ID: 7970141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats.
    Dall'olio R; Rimondini R; Gandolfi O
    Pharmacol Res; 1997 Sep; 36(3):203-9. PubMed ID: 9367665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse.
    Starr MS; Starr BS
    Eur J Pharmacol; 1993 Dec; 250(2):239-46. PubMed ID: 7906652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
    Boldry RC; Chase TN; Engber TM
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1454-9. PubMed ID: 7903390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801.
    Goodwin P; Starr BS; Starr MS
    J Neural Transm Park Dis Dement Sect; 1992; 4(1):15-26. PubMed ID: 1531757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF; Sheng J
    J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of D1 receptor mechanisms in the potentiation of motor responses to L-dopa and apomorphine by MK 801 in the reserpine-treated mouse.
    Kaur S; Starr MS; Starr BS
    J Neural Transm Park Dis Dement Sect; 1994; 8(1-2):107-16. PubMed ID: 7893372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with MK-801 affects the behavioral response to both D1 and D2 dopamine agonist in the one-trial inhibitory avoidance.
    Mele A; Castellano C; Oliverio A
    Psychopharmacology (Berl); 1995 Oct; 121(3):401-5. PubMed ID: 8584624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat.
    Dall'Olio R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1992; 107(4):591-4. PubMed ID: 1534911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.